Entera Bio Ltd.
ENTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001638097
No open-market purchases or sales by Entera Bio Ltd. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $19.0M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Entera Bio Ltd. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- −2 vs. Q3 2021
- Shares held
- 5.66M
- −9.73K (−0.2%) vs. Q3 2021
- Total value
- $15.9M
- −$10.8M (−40.4%) vs. Q3 2021
- New holders
- 2
- 2 more added
- Sold out
- 4
- 4 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $19.0M |
| Q1 2026 | 26 | $8.68M |
| Q4 2025 | 22 | $18.1M |
| Q3 2025 | 22 | $17.7M |
| Q2 2025 | 19 | $19.4M |
| Q1 2025 | 18 | $17.4M |
| Q4 2024 | 14 | $15.9M |
| Q3 2024 | 17 | $10.1M |
| Q2 2024 | 15 | $9.75M |
| Q1 2024 | 15 | $7.11M |
| Q4 2023 | 10 | $2.44M |
| Q3 2023 | 12 | $1.87M |
| Q2 2023 | 12 | $2.17M |
| Q1 2023 | 9 | $3.28M |
| Q4 2022 | 12 | $415.9K |
| Q3 2022 | 9 | $4.85M |
| Q2 2022 | 10 | $6.54M |
| Q1 2022 | 12 | $14.2M |
| Q4 2021 | 12 | $15.9M |
| Q3 2021 | 14 | $26.7M |
| Q2 2021 | 14 | $30.6M |
| Q1 2021 | 8 | $7.57M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Entera Bio Ltd.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,275 | $6.99M | 3.84% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 2,353,000 | $6.62M | 0.12% | 00.0% | Unchanged |
| ARK Investment Management LLCSuperinvestorARK Invest | 690,922 | $1.95M | 0.01% | +7,915+1.2% | Added |
| Renaissance Technologies LLC | 40,100 | $113.0K | 0.00% | +40,100 | New |
| Citadel Advisors LLC | 27,588 | $78.0K | 0.00% | −12,270−30.8% | Reduced |
| Geode Capital Management, LLC | 17,597 | $49.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 13,866 | $39.0K | 0.00% | −2,307−14.3% | Reduced |
| Altium Wealth Management LLC | 11,830 | $33.0K | 0.00% | +11,830 | New |
| Susquehanna Fundamental Investments, LLC | 10,200 | $29.0K | 0.00% | −4,200−29.2% | Reduced |
| Morgan Stanley | 5,968 | $17.0K | 0.00% | +590+11.0% | Added |
| Simplex Trading, LLC | 912 | $2.00K | 0.00% | −18,529−95.3% | Reduced |
| JPMorgan Chase & Co | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 0 | $0 | 0.00% | −18,839−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −11,563−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,894−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −565−100.0% | Sold out |